

































































Q2ARCHIVAL REPORTToll-Like Receptor 4 Regulates Chronic Stress-Induced
Visceral Pain in Mice
Monica Tramullas, Beate C. Finger, Rachel D. Moloney, Anna V. Golubeva, Gerard Moloney,
Timothy G. Dinan, and John F. CryanBackground: Functional gastrointestinal disorders, which have visceral hypersensitivity as a core symptom, are frequently comorbid
with stress-related psychiatric disorders. Increasing evidence points to a key role for toll-like receptor 4 (TLR4) in chronic pain states of
somatic origin. However, the central contribution of TLR4 in visceral pain sensation remains elusive.
Methods: With pharmacological and genetic approaches, we investigated the involvement of TLR4 in the modulation of visceral pain.
The TLR4-deficient and wild-type mice were exposed to chronic stress. Visceral pain was evaluated with colorectal distension. Protein
expression levels for TLR4, Cd11b, and glial fibrillary acidic protein (glial cells markers) were quantified in the lumbar region of the spinal
cord, prefrontal cortex (PFC), and hippocampus. To evaluate the effect of blocking TLR4 on visceral nociception, TAK-242, a selective TLR4
antagonist, was administered peripherally (intravenous) and centrally (intraventricular and intra-PFC) (n ¼ 10–12/experimental group).
Results: The TLR4 deficiency reduced visceral pain and prevented the development of chronic psychosocial stress-induced visceral
hypersensitivity. Increased expression of TLR4 coupled with enhanced glia activation in the PFC and increased levels of proinflammatory
cytokines were observed after chronic stress in wild-type mice. Administration of a TLR4 specific antagonist, TAK-242, attenuated visceral
pain sensation in animals with functional TLR4 when administrated centrally and peripherally. Moreover, intra-PFC TAK-242
administration also counteracted chronic stress-induced visceral hypersensitivity.
Conclusions: Our results reveal a novel role for TLR4 within the PFC in the modulation of visceral nociception and point to TLR4 as a
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Visceral pain is a pronounced and, at times, dominantfeature of a variety of gastrointestinal disorders, includingirritable bowel syndrome (IBS) (1), many of which are
comorbid with stress-related psychiatric disorders. Recurrent,
episodic but often unpredictable painful events can exert a
disabling impact on daily life and result in impairment of several
domains of quality of life (2). Moreover, exposure to life stressors
is a well-known key factor affecting the presentation of visceral
pain symptomatology (3). To date there are no effective pharma-
cotherapeutic approaches to selectively treat this visceral hyper-
sensitivity, which in part is because the underlying molecular
mechanisms remain largely unknown (4).
Toll-like receptors (TLRs) are a family of pattern-recognition
receptors of the innate immune system. The TLRs represent key
mediators of innate host defense in the gut, involved in main-
taining mucosal as well as commensal homeostasis. Inflammation
and altered intestinal homeostasis underlie several diseases
affecting the gastrointestinal tract (5). Recent reports have
suggested an involvement of peripheral toll-like receptor 4
(TLR4) in patients suffering from IBS (6,7) and in animal models
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indicate a role for TLR4 in sensory information transmission from
the gastrointestinal tract (10,11). However, TLR4 is also expressed
within the central nervous system (CNS), predominately in micro-
glia (12). Microglia represent the first line of defense for the CNS,
acting as a sensor for pathological events (13).
Recently, data from animal models have suggested that spinal
microglia activation is an important component in the facilitation
and modulation of the hyper-responsive pain states such as
hyperalgesia and allodynia. Therefore, microglia activation is
poised to play a key role in the development and maintenance
of chronic pain from somatic (14,15) and visceral (16,17) origin.
Upon activation by exogenous and endogenous ligands, TLR4 can
trigger the activation of microglia (18). This fact coupled with the
strong link between microglia activation and pain facilitation have
thus suggested a direct role for TLR4 in nociception (19). Indeed,
the importance of TLR4 in pain has been emphasized by recent
evidence showing a role of spinal TLR4 in the initiation of
pathological pain states such as inflammatory (20,21) and neuro-
pathic (21–23) pain in preclinical models. Moreover, blocking
TLR4 has prevented (24) and reversed (25) the hyper-responsive
phenotypes in animal models of neuropathic pain. However, to
our knowledge, the central role of TLR4 on visceral nociception
under pathological conditions remains unknown. In addition,
whereas preclinical studies have mainly investigated the local-
ization of mechanisms underlying visceral pain within the spinal
cord (16,26), little attention has been paid in other pain-related
areas within the CNS at a supraspinal level (27).
In the present study, we investigated whether TLR4 exerts
a modulatory role in visceral nociception, under physiological
and pathological stress-induced conditions. We also evaluated
the association of visceral hypersensitivity with TLR4 expres-
sion in pain-related areas within the CNS along with microglia
activation, a process known to be related to the altered pain
sensation.BIOL PSYCHIATRY 2013;]:]]]–]]]





































































































































2 BIOL PSYCHIATRY 2013;]:]]]–]]] M. Tramullas et al.Methods and Materials
Animals
Male wild-type C3H/HeN and TLR4-deficient mice (C3H/HeJ)
were used in this study (5–6 weeks old upon arrival). The C3H/HeJ
do not express functional TLR4, because of naturally occurring
mutations in the TLR4 gene (28). Mice were split into separate
cohorts for behavioral testing (colorectal distension [CRD]) and for
harvesting of samples (naïve or post-stress) for protein level
analysis. Mice were group-housed (five/cage) except for social
defeat studies where mice were singly housed. Male CD1 mice
(n ¼ 40, 9–10 weeks old) were used as aggressors in the social
defeat procedure. Water and food were available ad libitum to all
mice throughout the whole study. The holding room was
temperature (21  11C) and humidity (55  10%) controlled
and under a 12-hour light/dark cycle (lights on 7:00 AM). All
animals were supplied by Harlan (Derby, UK).
All experiments were conducted in accordance with the
European Directive 86/609/EEC, the Recommendation 2007/526/
65/EC, and approved by the Animal Experimentation Ethics
Committee of University College Cork. All efforts were made to
minimize animal suffering and to reduce the number of animals
used.
Chronic Social Defeat/Overcrowding Procedure
This chronic stress procedure was carried out as described
previously (29,30). Briefly, mice were exposed to an unpredictable
mixed model of social defeat and overcrowding sessions for 19
days. Subsequently, all mice underwent social interaction testing
(Supplement 1).
Social Interaction Test
Twenty-four hours after the last stress, social avoidance
behavior was assessed as described previously (29–31) in the
social interaction test (Supplement 1).
Colorectal Distension
Colorectal distension is a procedure frequently used in mice
(32) and humans (33) to assess visceral pain. The CRD was carried
out as described previously (30,34) (Supplement 1).
Corticosterone Assay
Plasma corticosterone concentrations were measured with
commercially available enzyme immunoassay kits (Assay Designs,
Ann Arbor, Michigan) according to the instructions of the
manufacturer, as described in Supplement 1.
Surgery and Drug Administration
Mice were anaesthetized with isoflurane (1.5–2%) and placed
in a stereotaxic frame. The skull was exposed, and permanent
guide cannulas (22G) were implanted unilaterally above the
lateral ventricle (from bregma: anterior-posterior .45 mm,
medial/lateral 1.0 mm, dorsal/ventral [DV] 2.0 mm) and bilat-
erally above the prelimbic cortex region (from bregma: anterior-
posterior 1.9 mm, medial/lateral /.5 mm, DV 2.0 mm)
according to the atlas of Franklin and Paxinos (35) and fixed on
the skull with dental cement. A 28G dummy cannula was inserted
in the guide cannula to prevent clogging. Mice were allowed to
recover 5 days after the surgery; the weight changes were
monitored daily. Microinjections were performed with a 28G
injection cannula extended .5 mm beyond the tip of the guiding
cannula (the final DV coordinate 2.5 mm) attached to flexible
plastic tubing and a Gastight Hamilton syringe.www.sobp.org/journalTAK-242 (Discovery Fine Chemicals, Wimborne, United Kingdom),
a small-molecule and selective TLR4 antagonist (36), was dis-
solved in a fat emulsion, 50% soybean oil (Sigma-Aldrich, Dublin,
Ireland) in saline, and prepared fresh daily. Administrations were
performed centrally into the lateral ventricle (intraventricular
.02 mg/mL, 2 mL) and in the prefrontal cortex (PFC) (.02 mg/mL,
.5 mL in each hemisphere) 20 min before CRD or peripherally into
the tail vein (10 mg/kg, 100 mL) 1 hour before CRD. After the
intraventricular and PFC experiments, cannula placement was
verified by injection of ink followed by brain dissection to deter-
mine ventricular flow of the ink or placement verification in the
PFC. Data from animals with incorrectly placed cannulas were
discarded from the experiments.
Spleen Cytokine Assays
Measurements of proinflammatory cytokines interleukin (IL)6
and tumor necrosis factor (TNF)α on spleen cells cultured with
lipopolysaccharide (LPS) (Sigma-Aldrich) was carried out with
custom mouse Multi-spot 96-well plates (Meso Scale Discovery,
Rockville, Maryland) according to instructions of the manufacturer
as described in Supplement 1.
Western Blot
Western blot was performed as previously described (37) to
determinate the protein levels of TLR4, Cd11b, and glial fibrillary
acidic protein (GFAP) (Supplement 1).
Immunofluorescence Staining
The CRD-naïve mice were sacrificed without anesthesia, and the
brains were snap-frozen and stored at 801C. Slices were incu-
bated with anti-TLR4 overnight followed by the incubation with
the secondary antibody conjugated with Alexa488 (Supplement 1).
Quantitative Real-Time Polymerase Chain Reaction
Total RNA was extracted from PFC samples with the Qiagen
RNeasy Lipid Mini Kit (Qiagen, Valencia, California). Complementary
DNA was synthesized with 1 mg total RNA with random primers.
Quantitative changes in messenger RNA (mRNA) levels were
estimated by real time-polymerase chain reaction (Supplement 1).
Statistical Analysis
Statistical differences between groups were analyzed by
repeated measures one- or two-way analysis of variance followed
by Bonferroni post hoc test. Independent-sample t tests were used
to compare two independent groups. All tests were performed at
a significance level of p  .05. All analysis was carried out with
SPSS 18.0 for windows (SPSS, Chicago, Illinois). All graphs show
mean values  SEM with *p  .05; **p  .01; ***p  .001.Results
TLR4 Deficiency Reduces Visceral Nociceptive Responses and
Prevents Development of Stress-Induced Visceral
Hypersensitivity
Mice deficient in TLR4 underwent CRD to assess visceral pain, in
an exploration of whether TLR4 plays a modulatory role in visceral
nociception. Absence of functional TLR4 triggered a decrease in
visceral sensitivity (genotype: F1,14 ¼ 7.611; p .05) (Figure 1A) along
with an increased pain threshold (t ¼ 2.228; p  .05) (Figure 1D).
These results are consistent with a hypoalgesic phenotype when
compared with wild-type mice, suggesting a modulatory role of TLR4

































































































































Figure 1. Effects of toll-like receptor 4 (TLR4) deficiency on visceral nociception. Visceral sensitivity to colorectal distension (ascending paradigm from 10
to 80 mm Hg) was assessed as the number of visceromotor responses over pressures. The TLR4-deficient mice presented with decreased visceral pain
responses (A), and chronic stress increased visceral pain responses in wild-type mice (B), but TLR4-deficient mice were resistant to stress-induced visceral
hypersensitivity (C). Pain thresholds were calculated as the pressure of the distending pulse at which the response evoked exceeded the mean baseline
activity plus three times the SD. Mice lacking functional TLR4 demonstrated increased pain threshold (D), whereas chronic stress decreased the pain
threshold in wild-type mice (E) but not in TLR4-deficient mice (F). *p  .05; **p  .01; independent sample t test or two-way analysis of variance followed
by Bonferroni post hoc test. Baseline response to colorectal distension was not different between individual groups/conditions; data represent mean
 SEM.
M. Tramullas et al. BIOL PSYCHIATRY 2013;]:]]]–]]] 3In gastrointestinal disorders, the symptomatology of visceral
pain has been causally associated with exposure to chronic
stressful events (26,30,38,39). We have recently established that
chronic psychosocial stress induces visceral hypersensitivity in
mice (30). Hence, we further investigated whether TLR4 modu-
lates this pathological state of stress-induced visceral pain. As
expected, after chronic stress mice with normal TLR4 functionality
showed a pronounced increase in visceral pain responses
(genotype  stress: F1,28 ¼ 5.100; p  .05) (Figure 1B). However,
this sensitization to noxious visceral stimuli was absent in TLR4-
deficient mice (Figure 1C), suggesting a key role for TLR4 as a
modulator under this pathological state of stress-induced visceral
pain. In line with these results, the pain threshold was signifi-
cantly decreased in wild-type mice after chronic stress but not in
TLR4-deficient mice (genotype  stress: F1,28 ¼ 4.7; p  .05)
(Figure 1E,F). Interestingly, TLR4-deficient mice responded
normally in other aspects to chronic stress (30). Wild-type and
TLR4-deficient mice exhibited an equal decrease in the social
interaction ratio (stress: F1,30 ¼ 14.63; p  .001), as illustrated by
social avoidance in the social interaction test (Figure S1 in
Supplement 1), suggesting a stress-induced social avoidance
phenotype independent of TLR4 signaling. Moreover, chronic stress
caused an overall decrease in adipose mass (stress: F1,43 ¼ 49.41;p  .001) (Figure S2A in Supplement 1), which was more
pronounced in mice with TLR4 deficiency (stress  genotype:
F1,43 ¼ 10.51; p  .01). Consequently, animals exposed to stress
gained a significant amount of lean mass (stress: F1,43 ¼ 12.03;
p  .01) (Figure S2B in Supplement 1), with a higher increase in
stress mice lacking functional TLR4 (stress  genotype: F1,43 ¼
12.03; p  .01). Evening corticosterone levels were significantly
decreased in all stress animals independent of genotype (stress:
F1,28 ¼ 4.04; p  .05) (Figure S2C in Supplement 1) as previously
described for this protocol of social defeat/overcrowding stress
(30,40).
TAK-242, a Selective TLR4 Antagonist, Reduces Visceral
Sensitivity in Wild-Type Mice and Reverses the Visceral
Hypersensitive Phenotype in Stressed Mice
We further proved that it is indeed TLR4 that regulates visceral
pain perception by administration of a small-molecule and
selective TLR4 antagonist, TAK-242. This compound successfully
attenuated visceral pain sensation in mice with functional TLR4
when administrated peripherally (treatment: F1,11 = 18.993; p 
.001) (Figure 2A) and remained without effects on pain behavior
in mice with TLR4 deficiency (Figure 2B). Also blocking TLR4


































































































































Figure 2. TAK-242 decreases visceral pain and reverses the visceral hypersensitive phenotype in stressed mice. Administration of the toll-like receptor 4
(TLR4) antagonist TAK-242 decreased visceral pain responses in mice with functional TLR4 when administered peripherally (intravenous 10 mg/kg) (A) but
not in TLR4-deficient mice (B). Similarly, administration of TAK-242 elevated pain thresholds in wild-type mice (D) but was ineffective in TLR4-deficient
mice (E). Moreover, administration of TAK-242 peripherally (intravenous 10 mg/kg) after exposure to chronic stress decreased the pain response to control
levels (C). Also, the antagonist normalized the stress-induced decrease in the pain threshold in wild-type mice (F). *p  .05; **p  .01; ***p  .001;
independent sample t test or one-way analysis of variance followed by Bonferroni post hoc test; baseline response to colorectal distension was not
different between individual groups/conditions; data represent mean  SEM.
4 BIOL PSYCHIATRY 2013;]:]]]–]]] M. Tramullas et al.(t ¼ 2.107; p  .05) (Figure 2D) but was ineffective in TLR4-
deficient mice (t ¼ .0556; p ¼ ns) (Figure 2E). Similarly, admin-
istration of TAK-242, robustly counteracted chronic stress-induced
visceral hypersensitivity (IV: treatment: F1,38 ¼ 209; p  .001)
(Figure 2C). Along with the decreased visceral pain responses,
TAK-242 administration significantly increased the pain threshold
after chronic stress (t ¼ 3.67; p  .01) (Figure 2F).
Chronic Psychosocial Stress Increases LPS-Induced
Stimulation of Spleen Cytokines and Peripheral TAK-242
Administration Counteracts Inflammatory Phenotype in
Stressed Mice
After spleen stimulation with LPS, a TLR4 agonist, wild-type
mice exposed to chronic psychosocial stress exhibited an
increased spleen level of IL6 (F2,37 ¼ 14.33; p  .001) (Figure 3)
and TNFα (F2,35 ¼ 3.92; p  .05) compared with the control group.
Moreover, peripheral administration of TAK-242 inhibited LPS-
stimulated release of spleen IL6 and TNFα after chronic stress.
Intracerebroventricular TAK-242 Reduces Visceral Sensitivity
in Wild-Type Mice
Although TAK-242 is a very small molecule and highly
lipophilic, it is not known whether TAK-242 could cross the brain
blood barrier. Due to this fact we aimed to investigate whetherwww.sobp.org/journalTLR4 is modulating visceral pain at the central level. The central
administration of TAK-242 into the lateral ventricle (intraventric-
ular) significantly reduced visceral pain sensation in mice with
functional TLR4 (treatment: F1,17 ¼ 29.836; p  .001) (Figure 4A)
and increased the pain threshold (t ¼ 2.687; p  .05) (Figure 4C).
These results imply a central modulatory role for TLR4 in visceral
nociception.
Visceral Hypersensitivity Is Associated with Increased TLR4
Expression in the PFC and Hippocampus But Not in Lumbar
Region of Spinal Cord
Even though other pathological pain states as inflammatory
and neuropathic pain have been associated with alterations of
TLR4 at the spinal cord level (20–23), spinal TLR4 expression has
not been studied in models of visceral hypersensitivity. We
assessed the levels of TLR4 in the spinal cord in the model of
visceral hypersensitivity in CRD-naïve mice, given that our data also
identify TLR4 as an important target in the central modulation of
visceral nociception on a behavioral level. In the lumbar region of
the spinal cord, protein levels of TLR4 were unchanged in stressed
mice (t = .484; p = ns) (Figure S3) when compared with the control
group. Whether TLR4 within the CNS is involved in stress-induced
visceral hypersensitivity at central level, TLR4 expression could be

































































































































Figure 3. Effects of chronic stress on cytokine levels after lipopolysac-
charide (LPS) spleen stimulation. Cytokine levels of interleukin (IL)6 and
tumor necrosis factor (TNF)α in spleen cell culture supernatant after
stimulation with LPS (1 μg/mL, 371C, 24 hours) were measured in wild-
type mice or control subjects exposed toQ14 chronic psychosocial stress (24
hours after the last stress session) or 1 hour after TAK-242 intravenous
administration after the exposure to chronic psychosocial stress. Exposure
to chronic psychosocial stress significantly increased spleen levels of IL6
and TNFα after the stimulation with LPS, compared with control mice.
Moreover, peripheral administration of TAK-242 blocked the LPS-induced
stimulation of spleen IL6 and TNFα. *p  .05; ***p  .001 versus control;
#p  .05; ##p  .01 versus stress; one-way analysis of variance followed by
Bonferroni post hoc test; data represent mean  SEM.
M. Tramullas et al. BIOL PSYCHIATRY 2013;]:]]]–]]] 5Thus, to further pinpoint whether TLR4 was altered in other
pain-related regions within the CNS, we evaluated the levels of
expression of TLR4 in the PFC and the hippocampus, two relevant
brain areas involved in pain modulation and vulnerable to exhibit
changes in response to stress (41). In addition, recent evidence
has shown the importance of PFC and hippocampus activation in
response to colorectal stimulation (27,42,43). As shown in Figure 5
and Figure S4 in Supplement 1, the levels of TLR4 were
significantly increased in the PFC (t ¼ 4.91; p  .01) (Figure 5A)
and hippocampus (t ¼ 3.41; p  .01) (Figure S4A) after chronic
stress, when compared with control mice. Furthermore, as shown
in Figure 5D, immunofluorescence staining confirmed the expres-
sion of TLR4 in the PFC.
Enhanced TLR4 Expression and Visceral Hypersensitivity Is
Associated with Glia Activation in PFC But Not in
Hippocampus
So far, studies have linked the etiology of visceral pain with
glial cell activation, including microglia and astrocytes in the CNS
(16,44). Because TLR4 is predominantly expressed on microglia
within the CNS (12), we hypothesize a direct link between the
activation of microglia and the enhanced expression of TLR4 in
the PFC and the hippocampus and, hence, the modulation of
visceral pain. Indeed, the levels of activated microglia within the
PFC showed the same profile of increase as described for TLR4,
after chronic stress (stress: F1,18 ¼ 24.90; p  .001) (Figure 5B).
However, exposure to chronic stress in TLR4-deficient mice also
triggered an increase in microglia (Figure 5B) without facilitating
an increase in visceral pain (Figure 1C,F). By contrast, in the
hippocampus, the levels of expression of the microglial marker
Cd11b were unchanged after chronic stress (stress: F1,19 ¼ .07;
p ¼ ns) (Figure S4B in Supplement 1). Because TLR4 is alsoexpressed on astrocytes, GFAP expression (an astrocyte marker)
was analyzed in the PFC. After chronic stress, the expression of
GFAP was significantly increased in the PFC in wild-type mice (t ¼
4.74; p  .01) (Figure 5C). These results suggest that the
upregulation of TLR4 along with glia activation in the PFC might
be involved in processing painful stimuli at a central level.
Intra-PFC TAK-242 Counteracts Visceral Hypersensitivity
Phenotype in Stressed Mice
To further confirm the regulatory role of TLR4 in the PFC in
visceral nociception, TAK-242 was administered bilaterally into
the PFC after exposure to chronic stress. As shown in Figure 4,
TAK-242 robustly counteracted chronic stress-induced visceral
hypersensitivity (treatment: F1,27 ¼ 34.56, p  .001) (Figure 4B)
and normalized the stress-induced decrease in the pain threshold
in wild-type mice (t ¼ 4.56; p  .001) (Figure 4D). These results
indicate that TLR4 is functionally involved in visceral pain
modulation in the PFC in a model of stress-induced visceral
hypersensitivity.
Chronic Psychosocial Stress Increases Proinflammatory
Cytokines Levels in PFC in Wild-Type But Not in TLR4-
Deficient Mice
Pathological pain is now understood in the context of
inflammation (central and peripheral) associated with tissue
damage (45). As a consequence of TLR4 activation, numerous
proinflammatory cytokines are released, triggering the initiation
and maintenance of chronic pain states (19,20,22). Because TLR4
is enhanced in the PFC, we assessed the mRNA expression levels
of TNFα, IL1-β, and IL6 in the PFC in wild-type and TLR4-deficient
mice after chronic stress (Table 1). The mRNA levels of TNFα
(F3,31 ¼ 3.35, p  .05) and IL1-β (F3,31 ¼ 4.75, p  .01) were
significantly increased in wild-type mice exposed to chronic stress
but not in TLR4-deficient mice. The mRNA levels of IL6 were
unchanged in all the conditions studied.Discussion
There is a growing awareness that visceral pain is not only a
common symptom in gastrointestinal disorders but also a key
determinant of disease severity and clinical impact (46). As a
consequence, the search for therapeutic targets to treat visceral
pain has become a major goal in preclinical and clinical research
alike (47). However, this has proven to be challenging, because
the underlying mechanisms leading to the expression of this form
of pain remain relatively undefined (4).
In the present study, we provide novel evidence that TLR4 is a
key modulator of visceral pain and thereby a potential thera-
peutic target for the treatment of visceral hypersensitivity. We
demonstrate that TLR4 deficiency reduced visceral sensitivity and
prevented the development of stress-induced visceral hyper-
sensitivity. Moreover, mice with normal TLR4 functionality
exposed to chronic psychosocial stress exhibited visceral hyper-
sensitivity. Our findings are in agreement with data showing a key
role for TLR4 in the induction of hypersensitive phenotypes in
mouse models of inflammatory and neuropathic pain (19–23).
With a pharmacological approach, we further confirmed that it is
indeed TLR4 that regulates visceral pain perception either
peripherally and centrally by administration of a small-molecule
and selective TLR4 antagonist, TAK-242. This compound success-
fully attenuated visceral pain sensation in wild-type mice and also
































































































































Figure 4. Central administration of TAK-242 decreases visceral pain in wild-type mice and into the prefrontal cortex (PFC) counteracts the visceral
hypersensitivity phenotype in stressed mice. Administration of the toll-like receptor 4 antagonist TAK-242 decreased visceral pain responses in mice with
functional toll-like receptor 4 when administered centrally (intraventricular [ICV] .04 mg/2 mL) (A). Also, central administration of TAK-242 elevated pain
thresholds in wild-type mice (C). Administration of TAK-242 into the PFC after exposure to chronic stress decreased the pain response to control levels (B).
Moreover, the antagonist normalized the stress-induced decrease in the pain threshold in wild-type mice (D). *p  .05; **p  .01; ***p  .001;
independent sample t test or one-way analysis of variance followed by Bonferroni post hoc test; baseline response to colorectal distension was not
different between individual groups/conditions; data represent mean  SEM.
6 BIOL PSYCHIATRY 2013;]:]]]–]]] M. Tramullas et al.to chronic stress. That TAK-242 counteracts visceral hypersensi-
tivity and also reduces visceral sensitivity under basal conditions
is relevant, because the efficacy of TAK-242 has been largely
evaluated in laboratory mice (48) and human clinical trials (49) in
the context of treating sepsis. However, beyond this, the
analgesic effect of TAK-242 has not to our knowledge been
described yet. TLR4 is expressed in the enteric nervous system
and in the dorsal root ganglia (10,11) and thus, peripheral
blocking of TLR4 could impede the sensory information trans-
mission from the gastrointestinal tract to the CNS. Additionally,
peripheral administration of TAK-242 blunted LPS-induced release
of spleen IL6 and TNFα after chronic stress. Interestingly, proin-
flammatory cytokines like IL6 and TNFα are important players in
both peripheral and central sensitization process, and they are
well-established to contribute to initiating and maintaining
chronic pain states (19,45). TAK-242 also decreased visceral pain
sensation when administered into the lateral ventricle, indicating
that TLR4 has a critical role in visceral pain processing at central
level. Furthermore, our data showed that the observed visceral
hypersensitivity after exposure to chronic stress is associated with
increased TLR4 protein levels within the PFC and the hippo-
campus in CRD-naïve mice, two brain areas involved in pain
modulation (50). Increasing evidence from human (42) andwww.sobp.org/journalnonhuman (43) functional imaging studies have demonstrated
a distinct pattern of PFC and hippocampus activation in response
to visceral pain (27). It is noteworthy that the PFC is a highly
vulnerable region in response to stress, undergoing neurochem-
ical and structural alterations that determine the deficits in PFC-
mediated behaviors (41). Thus, TLR4 could exhibit an important
regulatory function in processing painful stimuli in the PFC. Our
data are in agreement with a recently published study in which
TLR4 was upregulated in the PFC in mice after repeated restraint/
acoustic stress exposure (48). Nonetheless, the superficial layers of
the spinal dorsal horn have also been associated with the
modulation of abdominal pain (16,26). In our study, TLR4 levels
in the lumbar region of the spinal cord were unchanged under
chronic stress conditions in the model of visceral hypersensitivity.
However, we cannot rule out the presence of alterations in TLR4
expression in the spinal cord after stress exposure, because dorsal
(containing mainly nociceptive neurons) and ventral parts of the
spinal cord were taken for western blot analysis. Nevertheless, a
recently published report has shown a specific differential profile
for the involvement of the spinal TLR4 in inflammatory and
neuropathic pain (21).
Because TLR4 is predominately expressed in microglia within













































































































Figure 5. Effects of chronic stress on toll-like receptor 4 (TLR4) expression and glia activation in the prefrontal cortex (PFC). Western blot analysis for TLR4,
Cd11b (microglia marker), and glial fibrillary acidic protein (GFAP) (astrocyte marker) in the PFC protein expression of TLR4 was significantly increased in
the frontal cortex (A) after chronic stress when compared with control mice. Microglia expression (Cd11b) in the PFC was significantly increased in wild-
type but also was moderately increased in TLR4-deficient mice after chronic stress (B). Also, GFAP expression was significantly increased after exposure to
chronic stress (C). Representative image of TLR4 immunoreactivity in the PFC of wild-type mice (D). The nuclei were stained with 4’,6-diamidino-
2-phenylindole (DAPI). Scale bar: 50 mm. *p  .05; **p  .01; ***p  .001; independent sample t test or two-way analysis of variance followed by Bonferroni
post hoc test; data represent mean  SEM expressed as percentage of the control group.
Q15
M. Tramullas et al. BIOL PSYCHIATRY 2013;]:]]]–]]] 7etiology of somatic (15,49) and visceral (16,17) pain, we showed
that stress-induced visceral hypersensitivity and enhanced TLR4
expression in the PFC were associated with microglia activation,
as assessed through the increased levels of Cd11b. Interestingly,
although TLR4-deficient mice displayed no stress-induced visceral
hypersensitivity, we also observed an increase in microglia


















Table 1. Cytokine mRNA Expression in PFC of Wild-Type and TLR4
Wild-Type TLR4-Deficient
Control Stress Control Stress
TNFα 1.0  .23 2.15  .46a .80  .35 .86  .22
IL1β 1.0  .12 1.40  .08b .87  .07 .95  .14
IL6 1.0  .17 1.25  .11 1.18  .24 1.24  .15
Cytokine messenger RNA (mRNA) expression (expressed as fold
change vs. the wild-type control group) in prefrontal cortex (PFC) of
wild-type and toll-like receptor 4 (TLR4) exposed to either chronic
psychosocial stress or nonstressed (control) procedure. IL, interleukin;
TNF, tumor necrosis factor.
ap  .05 versus control wild-type; one-way analysis of variance
followed by Bonferroni post hoc test; data represent mean  SEM.
bp  .01 versus control wild-type; one-way analysis of variance
followed by Bonferroni post hoc test; data represent mean  SEM.indicating a dissociation between the functional nociceptive
changes and microglia activation. It is worth noting that previous
reports showed decreased microglia activation in TLR4-deficient
mice after nerve injury (22). By contrast, no changes in microglia
levels were found in the hippocampus after chronic stress, either
in wild-type or TLR4-deficient mice. Along with microglia activa-
tion in the PFC, the expression of GFAP, an astrocyte marker, was
also increased in wild-type mice exposed to chronic stress.
To further confirm the concept that it is TLR4 within the PFC
that is responsible for mediating chronic stress-induced visceral
hypersensitivity, we administered TAK-242 directly into the PFC in
animals that underwent our psychosocial stress paradigm and
successfully blunted the visceral hypersensitivity. It is noteworthy
that after stress, when visceral hypersensitivity is present in mice
with functional TLR4, mRNA levels of TNFα and IL1β were
increased in the PFC. Thus, intra-PFC blockade of TLR4 could
prevent the increased mRNA expression of TNFα and IL1β after
chronic stress. Our data indicated that, from a part of the
peripheral role of TLR4 in visceral pain modulation, TLR4 shows
an important regulatory function in processing painful stimuli in
the PFC. Additionally, our data are consistent with the fact that
the blockade of TLR4 with specific molecules reverses the hyper-
responsive states in models of neuropathic pain (25).
It is of further interest to consider possible ligands of TLR4
































































































































8 BIOL PSYCHIATRY 2013;]:]]]–]]] M. Tramullas et al.have shown that the exposure to chronic stress triggers central
release of a variety of mediators from damage cells and oxidative
stress, including heat shock protein 70 mRNA (51,52) and
saturated fatty acids (53). These particular molecules can act as
endogenous mediators binding to TLR4 (53,54) and might there-
fore be associated with visceral hypersensitivity through the
release of proinflammatory cytokines as one plausible mecha-
nism. Several pain states are associated with excessive inflamma-
tion in both the periphery and the CNS, which contribute to the
initiation and maintenance of persistent pain (45,55). In our study,
the release of proinflammatory cytokines in the periphery and the
enhanced mRNA expression of cytokines in the PFC could be
involved in the mechanisms underlying stress-induced visceral
hypersensitivity. In addition, chronic stress also disrupts the
intestinal barrier (56–58), making it leaky and increasing the
circulating levels of immunomodulatory bacterial cell wall com-
ponents such as LPS, the main activator of TLR4. However, the
nature of the mediators involved in TLR4-mediated changes in
nociception (22) as well as the underlying mechanisms remain
unclear and warrant future research efforts (59).
Hence, we demonstrated that TLR4 is required to modulate
visceral pain under physiological conditions and also for the
initiation of pathological visceral pain states. In addition, the
selective pharmacological blockade of TLR4 in the PFC with TAK-
242 was able to counteract the hyper-responsive phenotype in an
animal model of stress-induced visceral hypersensitivity, indica-
tive of a novel role of TLR4 especially within the PFC in visceral
pain modulation. Thus, blocking TLR4 might be a potential
strategy to treat visceral hypersensitivity. Given the clinical
availability of TAK-242, human trials are warranted to test the
efficacy of TLR4 antagonists in functional gastrointestinal disor-
ders associated with visceral hypersensitivity, such as IBS.
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